trans-4-(6,8-dibromo-1,2-dihydroquinazolin-3(4H)-yl)cyclohexanol hydrochloride(CAS: 15942-08-2)

The compound is a white crystalline solid with a molecular weight of approximately 462.12 g/mol. It is slightly soluble in water and ethanol. Chemically, it shows moderate reactivity with nucleophiles and exhibits good stability under neutral conditions. It can be identified by its characteristic UV and IR spectra.

This compound is usually synthesized through a multi-step process involving bromination of a quinazoline derivative followed by coupling with cyclohexanol. The reaction is catalyzed by palladium-based catalysts and the yield is typically around 70-80%. The method ensures high selectivity and purity.

This compound is used in the pharmaceutical industry for its potential as a bioactive molecule. It also finds applications in the polymer industry for its specific chemical properties. Additionally, it is explored in sensor technology and semiconductor fabrication due to its unique chemical structure.

Proper personal protective equipment (PPE) such as gloves, goggles, and lab coats should be worn when handling this compound. Work should be conducted in a fume hood to minimize inhalation risks. Spills should be cleaned up with appropriate solvents and disposed of according to safety data sheet (SDS) guidelines. Always refer to the latest SDS for detailed safety information.